This study assessed whole-brain structural connectomes in 252 children treated for ALL during early phase of treatment and at end of therapy relative to 89 normal healthy age-similar controls. Both small worldness index and clustering coefficient were significantly lower in patients early and late in therapy relative to the controls but did not change during therapy. However, both characteristic path length and local efficiency significantly decreased during therapy. Decreased network integration and less efficient information transfer in patients treated for ALL is likely to result in decreased performance on neurocognitive testing by end of therapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords